Aflac Incorporated (AFL) Income Statement

An income statement shows a company's revenue, expenses, and profit over a reporting period.

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates in two segments, Aflac Japan and Aflac U.S.

Total Revenue Chart for Aflac Incorporated

Aflac Incorporated (AFL) revenue for FY2025 was USD 17.4B, a -8.8% change from FY2024. Aflac Incorporated's revenue grew from USD 954.8M in 1985 to USD 17.4B in 2025 (1726.4% over 40 years). Earnings per share grew from USD 0.63 in 2000 to USD 6.85 in 2025 (987.1%). Revenue compound annual growth rate: 5-year CAGR of -4.7%, 10-year CAGR of -1.8%, 20-year CAGR of 1.0%.

The most recent 8 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Revenue (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$60.89B
Implied Share Price
$121.45
Enterprise Value
$70.84B
Revenue (TTM)
$18.07B
EBITDA
$6.06B
Profit Margin
26.91%
Trailing P/E
13.10
Forward P/E
14.53
Price/Book (MRQ)
2.01
Price/Sales (TTM)
3.37
EV/EBITDA
0.00
EV/Revenue
3.87
Dividend Yield
1.97%
Book Value
$60.35
Free Cash Flow (FY2025)
$2.56B
Free Cash Flow Yield
4.20%

Snapshot as of 16th August 2026 — not point-in-time controlled, may lag the live market by a few days.